The human SART3 HAT domains (residues 1–691) and DUSP-UBL domain of USP15 (residues 1–226) were cloned into pET-28a (Novagen) to generate N-terminal histidine-tagged proteins. The N-domain (residues 1–333) and C-domain (residues 85–499) of human PRP31 were cloned into pET-32a (Novagen) as N-terminal histidine-tagged thioredoxin fusion proteins. All proteins were expressed in Escherichia coli Rosetta (DE3) cells with induction by 0.5 mM isopropyl-β-d-thiogalactoside at 18°C for 18 h. Proteins in 50 mM Tris–HCl (pH 8.0) and 150 mM NaCl buffer were purified with His-Trap affinity column (GE Healthcare) eluted with 25–500 mM imidazole. Affinity tags were removed with thrombin, and the resultant proteins were then further purified with a Superdex 200 26/60 gel filtration column (GE Healthcare) which had been pre-equilibrated with 50 mM Tris–HCl (pH 8.0) and 150 mM NaCl.
For the separation of protein complexes, cell lysates overexpressed with HA-SART3, Myc-USP4 and Flag-USP15 were co-fractionated by gel filtration with a Superdex 200 10/300 column (GE Healthcare) in a buffer containing 50 mM Tris–HCl (pH 7.4), 150 mM NaCl and 1 mM EDTA. Molecular weight markers (Sigma-Aldrich) with a range of 66 000–443 000 Da were used for size calibration. Eluted fractions (0.5 ml) were collected and aliquots were subject to the SDS-PAGE and detected by western blotting.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
 Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.